In addition, activation of TLR4 upregulates the expression of programmed death ligand 1 (PD-L1), which in turn inhibits the anti-tumor activity of T cells and promotes immune escape (Kang et al., 2020). This evidence concerns the gene TLR4 and neoplasm.